|
 | PRESIDENTDesiree E. Morgan, MD, FSABI |
| PRESIDENt ELECTIhab Kamel, MD, PhD, FSABI Dr. Kamel is the Chair of Radiology at Johns Hopkins Bayview Medical Center. Dr. Kamel joined Johns Hopkins faculty in 2000 and served as the Clinical Director of MRI from 2008 to 2019. He has led significant MRI expansion across the entire Johns Hopkins enterprise. He aslo led several MRI safety initiatives, while maintainng high quality imaging studies and improving patient access. Kamel is recognized globally by his membership in premiere radiology associations including the ACR, RSNA, ARRS and ISMRM. Dr Kamel chairs the Multisystem Section of "RadioGraphics" and he also chairs the Gastrointestinal Section of the American College of Radiology, repsonsible for creating Appropriateness Criteria for imaging. Dr. Kamel developed a multidisciplinary clinic that includes liver surgery, transplant surgery, hepatology, interventional radiology and oncology to discuss the diagnosis and management of complex liver cases. Parterning with other services and departments, Dr. Kamel assembled a research team focusing on hepatobiliary imaging, particularly oncologic application of functional MRI. He has over 260 peer-reviewed publications, 20 non-peer publications and 25 book chapters. |
| VICE PRESIDENTMatthew S. Davenport, MD, FSABI |
| TREASURERAvinash Kambadakone Ramesh, MD, FRCR, MBBS Dr. Avinash Kambadakone-Ramesh is a radiologist in Boston, Massachusetts and is affiliated with Massachusetts General Hospital. He received his medical degree from Kasturba Medical College Manipal and has been in practice between 11-20 years. Dr. Kambadakone-Ramesh accepts several types of health insurance, listed below. He is one of 275 doctors at Massachusetts General Hospital who specialize in Radiology. |
 | SecretaryAndrew Smith, MD, FSABI University of Alabama at Birmingham Dr. Smith is Professor, Vice Chair of Innovation, Co-Director of AI, and Chief of CT in Radiology and Director of the Human Imaging Core Lab at the University of Alabama at Birmingham. His clinical areas of expertise are in abdominal imaging, oncologic imaging, and augmented intelligence in imaging. He in the inventor on over 20 patents and has led FDA 510(k) clearance on multiple imaging technologies. Dr. Smith is a co-founder and advisor of several AI startup companies focused on AI development, validation, and FDA clearance, AI for advanced cancer imaging and reporting, and AI for opportunistic screening and care coordination. He enjoys time with his family, and his main hobby is epee fencing. |
 | chief membership officerNicole Hindman, MD, FSABI Dr. Hindman is a Professor of Radiology and Surgery at NYU Grossman School of Medicine. Genitourinary imaging has been the main clinical and research focus of her radiologic career. In this field, she has focused on the applicability of the Bosniak classification of renal cysts and the role of MR in imaging of female pelvic conditions (with focus on endometriosis, fibroids and leiomyosarcoma). She has achieved national recognition in Radiology, chairing committees for the American Board of Radiology and the American College of Radiology, developing national and international standards in radiology, and publishing over 80 papers. She serves on the Editorial Board as an Associate Editor for Radiology and also for the Journal of Computed Tomography (JCAT). Internally, she has had the privilege of serving as the Director of Female Pelvic Imaging and the Institutional MR Safety MD and as the Vice Chair of Diversity and Health Equity. |
 | IMMEDIATE PAST PRESIDENTIvan Pedrosa, MD, PhD, FSABI Dr. Pedrosa is Professor (tenure) of Radiology, Urology, Advanced Imaging Research Center, and Biomedical Engineering at the University of Texas Southwestern Medical Center. He serves as the Vice-Chair of Research in the Department of Radiology. He is the holder of the Jack Reynolds, M.D., Chair in Radiology and Co-Leader of the Kidney Cancer Program at the Harold C. Simmons Comprehensive Cancer Center. His translational research program in genitourinary cancers focuses on implementing novel quantitative imaging techniques for the prediction of aggressiveness, angiogenesis, and response to novel therapies, primarily focusing on MRI. |
|
|
|
